6MU6: HIV-1 BG505 SOSIP.664 Prefusion Env Trimer

Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom. Determined by X-ray diffraction at 2.55 Å resolution. Released 16 Jan 2019.

Method
X-ray diffraction
Resolution
2.55 Å
Organisms
Human immunodeficiency virus 1, Homo sapiens
Chains
6
Atoms
10,185
Mol. weight
156.35 kDa
Ligands
JYV, NAG
Released
16 Jan 2019

Explore 6MU6 in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

6MU6 contains 35 α-helices and 111 β-strands across 6 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain B: 6 helices, 3 β-strands

ElementResiduesLengthSheet
β-strand52911
α-helix530-5334
α-helix537-5415
α-helix570-59425
β-strand603-60972
α-helix620-6234
β-strand62711
α-helix628-6347
α-helix639-66022
Chain D: 2 helices, 11 β-strands
ElementResiduesLengthSheet
β-strand3-643
β-strand19-2573
β-strand2713
α-helix29-313
β-strand34-4074
β-strand46-5164
β-strand57-5934
α-helix61-633
β-strand67-72D103
β-strand74-8293
β-strand88-9474
β-strand102-10324
β-strand107-10824
Chain E: 2 helices, 13 β-strands
ElementResiduesLengthSheet
β-strand515
β-strand916
β-strand20-2127
β-strand2415
β-strand32-3876
β-strand45-4956
β-strand53-5426
α-helix551
β-strand62-6657
β-strand7015
β-strand71-7557
α-helix80-823
β-strand85-9176
β-strand97-9826
β-strand102-10326
Chain G: 12 helices, 41 β-strands
ElementResiduesLengthSheet
β-strand35-4062
β-strand45-4738
β-strand53-5649
β-strand66-67210
α-helix71-733
β-strand75-7629
α-helix77-782
β-strand83-8648
β-strand91-94411
α-helix100-11516
β-strand121112
α-helix123-1253
β-strand129-133513
α-helix151-1533
β-strand154-162913
β-strand169-177913
α-helix178-1803
β-strand181-183313
β-strand190-193413
β-strand200-203412
β-strand208-209210
β-strand215114
β-strand216-21839
α-helix219-2202
β-strand223-22868
β-strand236-239411
β-strand242-24548
β-strand24719
β-strand251114
β-strand259-261315
β-strand271-273315
β-strand284116
β-strand285-3082415
β-strand316-323915
β-strand330-334515
α-helix335-35016
β-strand359-361316
α-helix369-3724
β-strand374-378517
β-strand381-385517
β-strand393-395316
β-strand413-417515
β-strand418-421417
β-strand423-425312
α-helix4261
β-strand432-435412
α-helix437-4404
β-strand441-4521215
β-strand454-456316
β-strand466-470516
α-helix476-4838
β-strand486-49168
β-strand494-49962
Chain H: 6 helices, 23 β-strands
ElementResiduesLengthSheet
β-strand3-7518
β-strand11-12219
β-strand18-25818
β-strand33-39720
β-strand45-51720
β-strand57-59320
α-helix64-663
β-strand67-69318
β-strand72118
β-strand77-82618
α-helix84-863
β-strand88-100A1420
β-strand100J-1011020
β-strand105-107320
β-strand108-109219
α-helix113-1142
β-strand115121
β-strand118-122522
β-strand133-1431122
β-strand144121
β-strand149-152423
α-helix153-1553
β-strand157123
β-strand161-168822
β-strand174-1831022
α-helix184-1874
β-strand192-197623
α-helix199-2013
β-strand205-209523
Chain L: 7 helices, 20 β-strands
ElementResiduesLengthSheet
β-strand9-14624
β-strand18-22525
β-strand31-38824
β-strand45-48424
β-strand62-63225
α-helix69-713
β-strand72-76525
α-helix80-823
β-strand85-92824
β-strand97120
β-strand102-107624
α-helix109-1113
β-strand112126
β-strand117-119327
α-helix120-1223
α-helix123-1275
β-strand131-1401027
β-strand141126
β-strand145-151728
β-strand154-156328
β-strand160-162327
α-helix163-1653
β-strand166-167227
β-strand173-181927
α-helix183-1875
β-strand192-198728
β-strand201-207728

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Envelope glycoprotein gp160Bprotein153Human immunodeficiency virus 1Q2N0S6
35O22 scFv heavy chain portionDprotein134Homo sapiens
35O22 scFv light chain portionEprotein114Homo sapiens
Envelope glycoprotein gp160Gprotein481Human immunodeficiency virus 1Q2N0S6
3H109L Fab heavy chainHprotein244Homo sapiens
3H109L Fab light chainLprotein217Homo sapiens
Sequence of entity 1 (B), FASTA
>6MU6_1 Envelope glycoprotein gp160 (chains B)
AVGIGAVFLGFLGAAGSTMGAASMTLTVQARNLLSGIVQQQSNLLRAPEAQQHLLKLTVW
GIKQLQARVLAVERYLRDQQLLGIWGCSGKLICCTNVPWNSSWSNRNLSEIWDNMTWLQW
DKEISNYTQIIYGLLEESQNQQEKNEQDLLALD
Sequence of entity 2 (D), FASTA
>6MU6_2 35O22 scFv heavy chain portion (chains D)
QGQLVQSGATTTKPGSSVKISCKTSGYRFNFYHINWIRQTAGRGPEWMGWISPYSGDKNL
APAFQDRVNMTTDTEVPVTSFTSTGAAYMEIRNLTSDDTGTYFCAKGLLRDGSSTWLPYL
WGQGTLLTVSSAST
Sequence of entity 3 (E), FASTA
>6MU6_3 35O22 scFv light chain portion (chains E)
SQSVLTQSASVSGSLGQSVTISCTGPNSVCCSHKSISWYQWPPGRAPTLIIYEDNERAPG
ISPRFSGYKSYWSAYLTISDLRPEDETTYYCCSYTHNSGCVFGTGTKVSVLGQS
Sequence of entity 4 (G), FASTA
>6MU6_4 Envelope glycoprotein gp160 (chains G)
AENLWVTVYYGVPVWKDAETTLFCASDAKAYETEKHNVWATHACVPTDPNPQEIHLENVT
EEFNMWKNNMVEQMHTDIISLWDQSLKPCVKLTPLCVTLQCTNVTNAITDDMRGELKNCS
FNMTTELRDKKQKVYSLFYRLDVVQINENQGNRSNNSNKEYRLINCNTSAITQACPKVSF
EPIPIHYCAPAGFAILKCKDKKFNGTGPCPSVSTVQCTHGIKPVVSTQLLLNGSLAEEEV
MIRSENITNNAKNILVQFNTPVQINCTRPNNNTRKSIRIGPGQAFYATGDIIGDIRQAHC
NVSKATWNETLGKVVKQLRKHFGNNTIIRFANSSGGDLEVTTHSFNCGGEFFYCNTSGLF
NSTWISNTSVQGSNSTGSNDSITLPCRIKQIINMWQRIGQAMYAPPIQGVIRCVSNITGL
ILTRDGGSTNSTTETFRPGGGDMRDNWRSELYKYKVVKIEPLGVAPTRCKRRVVGRRRRR
R
Sequence of entity 5 (H), FASTA
>6MU6_5 3H109L Fab heavy chain (chains H)
QVQLQESGPGLVKPSETLSLTCTVSGGSISNYYWSWIRQSPGKGLEWIGYISDSESTNYN
PSLKSRVIISVDTSKNQLSLKLNSVTAADSAIYYCARAQQGKRIYGMVSFGEFFYYYYMD
VWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTS
GVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKGLE
VLFQ
Sequence of entity 6 (L), FASTA
>6MU6_6 3H109L Fab light chain (chains L)
SVTSYVRPLSVALGETASISCGRQALGSRAVQWYQHRPGQAPILLIYNNQDRPSGIPERF
SGTPDINFGTRATLTISGVEAGDEADYYCHMWDSRSGFSWSFGGATRLTVLGQPKAAPSV
TLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAAS
SYLSLTPMQWKMHKSYSCQVTHEGSTVEKTVAPTECS

Ligands and cofactors

IDNameFormulaCopies
JYV(2R)-{1-[{7-[2-({[3-(dimethylamino)propyl](methyl)amino}methyl)-1,3-thiazol-4-y…C33 H39 N7 O3 S1
NAG2-acetamido-2-deoxy-beta-D-glucopyranoseC8 H15 N O610

Primary citation

Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry. Lai, Y.T., Wang, T., O'Dell, S. et al. Nat Commun (2019) 10:47-47. DOI 10.1038/s41467-018-07851-1 · PubMed

Other PDB entries of the same protein (UniProt Q2N0S6), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 6MU6 directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.